# Can Adropin protect against cardiovascular aging in sepsis-induced cardiomyopathy?

Canonical source: https://retacompare.com/research/can-adropin-protect-against-cardiovascular-aging-in-sepsis-induced-cardiomyopathy

Peptide Longevity Q&A · 2026-01-15


    Adropin has shown protective effects against sepsis-induced cardiomyopathy, highlighting its potential role in preserving cardiovascular function. Research indicates that adropin mitigates myocardial injury through anti-inflammatory, anti-apoptotic, and antioxidative mechanisms, which may contribute to cardiovascular aging and overall heart health.

 What the research shows

The study investigated the protective role of adropin in sepsis-induced cardiomyopathy (SIMD) using cellular and mouse models. The researchers assessed cardiac function and myocardial changes through ultrasonography and hematoxylin-eosin (HE) staining. They also performed molecular analyses of inflammation, apoptosis, and oxidative stress-related proteins using quantitative real-time PCR (qRT-PCR) and Western blot techniques. Additionally, oxidative stress levels were evaluated using dihydroethidium (DHE) staining and flow cytometry. The results demonstrated that adropin administration significantly improved cardiac function and reduced myocardial edema and inflammatory cell infiltration compared to the LPS model group.

 Why it matters for longevity

The findings from this research are significant in the context of cardiovascular aging. Sepsis-induced cardiomyopathy is associated with increased mortality rates, and the absence of targeted therapies underscores the need for effective interventions. Adropin's ability to reduce inflammation, apoptosis, and oxidative stress suggests that it may play a crucial role in maintaining cardiovascular health, particularly in aging populations. By mitigating the detrimental effects of sepsis on cardiac function, adropin could contribute to improved healthspan and longevity.

 Key findings at a glance

Adropin provides protective effects against sepsis-induced cardiomyopathy.

Administration of adropin improved cardiac function in both cellular and mouse models.

Adropin reduced myocardial edema and inflammatory cell infiltration.

It down-regulated pro-apoptotic protein bax and up-regulated anti-apoptotic protein bcl-2.

Adropin diminished levels of inflammatory factors such as TNF-α, IL-6, and IL-1β.

Oxidative stress was reduced, with increased antioxidant protein expression following adropin treatment.

 How Adropin works (background)

Adropin is known for its anti-inflammatory, antioxidant, and anti-apoptotic properties, which are critical in the context of cardiovascular health. In the study, adropin administration led to a significant reduction in reactive oxygen species (ROS) levels and increased the abundance of antioxidant stress proteins such as NQO1, GPX1, and Nrf2. The activation of the Nrf2/antioxidant response element (ARE) signaling pathway appears to be a key mechanism through which adropin exerts its protective effects, enhancing intracellular antioxidant protein expression and mitigating oxidative stress.

 Safety, caveats, and what we don't yet know

While the study presents promising findings regarding adropin's protective effects against sepsis-induced cardiomyopathy, it is important to acknowledge that this research is preclinical. The results were obtained from cellular and animal models, and further studies are needed to evaluate the safety and efficacy of adropin in human populations. Additionally, the long-term effects and potential side effects of adropin treatment remain to be investigated. Understanding the full scope of adropin's mechanisms and its applicability in clinical settings will require more extensive research.

 Bottom line

Adropin exhibits protective effects against sepsis-induced cardiomyopathy, suggesting its potential role in supporting cardiovascular health and longevity. Further research is necessary to fully understand its mechanisms and therapeutic applications.

 Related questions

 Does Adropin influence oxidative stress in aging cells?

Research indicates that adropin may reduce oxidative stress levels, which is crucial for maintaining cellular health and function in aging cells. Its antioxidant properties could contribute to improved longevity.

 Can Adropin enhance heart function in older adults?

While studies suggest that adropin improves cardiac function in preclinical models, further research is needed to determine its effects on heart function specifically in older adult populations.

 What role does Adropin play in inflammation reduction?

Adropin has demonstrated anti-inflammatory effects, significantly reducing inflammatory factors associated with sepsis-induced cardiomyopathy, which may have implications for managing age-related inflammatory conditions.

 Source: PubMed · Int Immunopharmacol · published 2026-01-15.

## Sources

- PubMed · Int Immunopharmacol: https://pubmed.ncbi.nlm.nih.gov/41391279/